Charity Evans

3.6k total citations · 1 hit paper
91 papers, 2.7k citations indexed

About

Charity Evans is a scholar working on Pathology and Forensic Medicine, Rheumatology and Geriatrics and Gerontology. According to data from OpenAlex, Charity Evans has authored 91 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pathology and Forensic Medicine, 19 papers in Rheumatology and 16 papers in Geriatrics and Gerontology. Recurrent topics in Charity Evans's work include Multiple Sclerosis Research Studies (56 papers), Pharmaceutical Practices and Patient Outcomes (16 papers) and Medication Adherence and Compliance (15 papers). Charity Evans is often cited by papers focused on Multiple Sclerosis Research Studies (56 papers), Pharmaceutical Practices and Patient Outcomes (16 papers) and Medication Adherence and Compliance (15 papers). Charity Evans collaborates with scholars based in Canada, United States and United Kingdom. Charity Evans's co-authors include Elaine Kingwell, Ruth Ann Marrie, Helen Tremlett, John D. Fisk, Yinshan Zhao, Feng Zhu, Christina Wolfson, Nathalie Jetté, José M.A. Wijnands and Marcus Koch and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Charity Evans

88 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence and prevalence of multiple sclerosis in Europe: a systematic review

2013 386 citations Elaine Kingwell, James Marriott et al. BMC Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charity Evans Canada	28	1.8k	470	436	360	293	91	2.7k
Yinshan Zhao Canada	26	1.7k 0.9×	594 1.3×	510 1.2×	313 0.9×	248 0.8×	85	2.4k
Charles N. Paidas United States	33	701 0.4×	417 0.9×	384 0.9×	460 1.3×	605 2.1×	88	3.7k
Shahram Bahmanyar Sweden	28	528 0.3×	187 0.4×	169 0.4×	323 0.9×	308 1.1×	98	2.3k
George F. Borm Netherlands	32	281 0.2×	449 1.0×	714 1.6×	406 1.1×	328 1.1×	62	3.5k
Margaret K. Vandervoort Canada	25	551 0.3×	485 1.0×	268 0.6×	216 0.6×	1.4k 4.8×	54	3.5k
Machaon Bonafede United States	28	345 0.2×	85 0.2×	383 0.9×	356 1.0×	399 1.4×	153	2.8k
Doron Comaneshter Israel	31	429 0.2×	154 0.3×	932 2.1×	174 0.5×	436 1.5×	143	2.9k
Antoni Sisó‐Almirall Spain	30	224 0.1×	213 0.5×	421 1.0×	205 0.6×	263 0.9×	113	2.7k
Guillaume Moulis France	23	325 0.2×	101 0.2×	298 0.7×	141 0.4×	302 1.0×	129	2.6k
I‐Jun Chou Taiwan	23	327 0.2×	234 0.5×	466 1.1×	114 0.3×	331 1.1×	77	2.0k

Countries citing papers authored by Charity Evans

Since Specialization

Citations

This map shows the geographic impact of Charity Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charity Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charity Evans more than expected).

Fields of papers citing papers by Charity Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charity Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charity Evans. The network helps show where Charity Evans may publish in the future.

Co-authorship network of co-authors of Charity Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Charity Evans. A scholar is included among the top collaborators of Charity Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charity Evans. Charity Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Feng, Charity Evans, John D. Fisk, et al.. (2023). Gastrointestinal conditions in the multiple sclerosis prodrome. Annals of Clinical and Translational Neurology. 11(1). 185–193. 10 indexed citations

Lix, Lisa M., et al.. (2022). The Impact of Age and Sex Concordance Between Patients and Physicians on Medication Adherence: A Population-Based Study. SHILAP Revista de lepidopterología. 4 indexed citations

Graf, Jonas, Huah Shin Ng, Feng Zhu, et al.. (2022). Emergency department use by persons with MS: A population-based descriptive study with a focus on infection-related visits. Multiple Sclerosis Journal. 28(11). 1825–1828. 4 indexed citations

Marrie, Ruth Ann, et al.. (2019). Association between disease-modifying therapies for multiple sclerosis and healthcare utilisation on a population level: a retrospective cohort study. BMJ Open. 9(11). e033599–e033599. 7 indexed citations

Wijnands, José M.A., Feng Zhu, Elaine Kingwell, et al.. (2018). Five years before multiple sclerosis onset: Phenotyping the prodrome. Multiple Sclerosis Journal. 25(8). 1092–1101. 85 indexed citations

Zhu, Feng, Elaine Kingwell, John D. Fisk, et al.. (2018). Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study. Journal of Neurology Neurosurgery & Psychiatry. 89(10). 1050–1056. 70 indexed citations

McKay, Kyla A., Charity Evans, John D. Fisk, et al.. (2017). Disease-Modifying Therapies and Adherence in Multiple Sclerosis: Comparing Patient Self-Report with Pharmacy Records. Neuroepidemiology. 48(3-4). 124–130. 6 indexed citations

Furber, Kendra L., et al.. (2017). Advances in the treatment of relapsing–remitting multiple sclerosis: the role of pegylated interferon β-1a. PubMed. Volume 7. 47–60. 5 indexed citations

Zhang, Tingting, Elaine Kingwell, Feng Zhu, et al.. (2017). Effect of adherence to the first-generation injectable immunomodulatory drugs on disability accumulation in multiple sclerosis: a longitudinal cohort study. BMJ Open. 7(9). e018612–e018612. 4 indexed citations

10.

Evans, Charity, Ruth Ann Marrie, Feng Zhu, et al.. (2016). Adherence and persistence to drug therapies for multiple sclerosis: A population-based study. Multiple Sclerosis and Related Disorders. 8. 78–85. 56 indexed citations

11.

Zhang, Thomas, Afsaneh Shirani, Yinshan Zhao, et al.. (2015). Beta‐interferon exposure and onset of secondary progressive multiple sclerosis. European Journal of Neurology. 22(6). 990–1000. 25 indexed citations

12.

Kingwell, Elaine, James Marriott, Nathalie Jetté, et al.. (2013). Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurology. 13(1). 128–128. 386 indexed citations breakdown →

13.

Mohammed, Somala, Charity Evans, George VanBuren, et al.. (2013). Treatment of bacteriobilia decreases wound infection rates after pancreaticoduodenectomy. HPB. 16(6). 592–598. 55 indexed citations

14.

Shirani, Afsaneh, Yinshan Zhao, Mohammad Ehsanul Karim, et al.. (2012). Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis. JAMA. 308(3). 247–56. 188 indexed citations

15.

Laubscher, Tessa, et al.. (2009). Collaboration between family physicians and community pharmacists to enhance adherence to chronic medications: opinions of Saskatchewan family physicians.. PubMed. 55(12). e69–75. 24 indexed citations

16.

Laubscher, Tessa, et al.. (2009). Collaboration between family physicians and community pharmacists to enhance adherence to chronic medications. Canadian Family Physician. 55(12). 7 indexed citations

17.

Taylor, Jeff & Charity Evans. (2009). Cough and cold medication use in young children: Pharmacist reaction to changes in Canada. Journal of the American Pharmacists Association. 49(6). 783–786. 1 indexed citations

18.

Blackburn, David, et al.. (2007). Cardiovascular risk reduction strategies in community pharmacy settings need real world angle. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 140(5). 295–297. 2 indexed citations

19.

Evans, Charity, et al.. (2004). Use and Abuse of Methylphenidate in Attention-Deficit/Hyperactivity Disorder. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 137(6). 30–35. 2 indexed citations

20.

Gray, Alastair, Andrew Kidd, James OʼBrien, & Charity Evans. (1989). Suspected adverse reactions to medicines during 1988. Veterinary Record. 124(12). 286–287. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact